AssayIndex
Reports by quarter

Reports submitted in 2025-Q1 · page 4

Anomaly rule set expanded from seven rules to eleven. Median purity for the quarter is 99.14 % area, n=664. Read the 2025-Q1 state-of-the-index report →

672 records17 pagesmedian on this page 99.33 %updated 30 Jul 2026
ReportCompoundSupplierLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2025-019608GHRP-2TFCTFC-2411-A2083Janoshik2025-Q199.722.09—Buyer-sourced0PASS
AX-2025-019363TirzepatideHYBHYB-2408-R7015Janoshik2025-Q198.424.63106.8Buyer-sourced0PASS
AX-2025-019047N-Acetyl Semax AmideASYASY-{CAT}-2147Janoshik2025-Q199.938.49—Buyer-sourced0PASS
AX-2025-018508SemaglutideWWBWWB-2501-K3141VendorInvestigate2025-Q198.334.07102.1Buyer-sourced1MARGINAL
AX-2025-018415SemaglutideWWBWWB-2502-W1846Medutest2025-Q199.395.31106.9Buyer-sourced1MARGINAL
AX-2025-020650GHRP-6SGNSGN-2411-N8496PeptideMeter2025-Q198.903.79100.9Buyer-sourced1FAIL
AX-2025-020636TirzepatideGL BiochemGLBI-2412-R8446PeptideMeter2025-Q198.824.4191.7Supplier-supplied0PASS
AX-2025-019779RetatrutideHomopeptideHOMO-2409-R4202Janoshik2025-Q198.893.25104.5Buyer-sourced0PASS
AX-2025-019060MK-677 (Ibutamoren mesylate)GSPGSP-2501-R2783PeptideMeter2025-Q199.435.6490.3Buyer-sourced0FAIL
AX-2025-018825BPC-157FGPFGP-2409-Y8596VendorInvestigate2025-Q199.855.2394.8Buyer-sourced0PASS
AX-2025-018744CJC-1295 (no DAC)QSCQSC-2411-D7855Janoshik2025-Q199.813.48—Supplier-supplied0PASS
AX-2025-018470TirzepatideWWBWWB-2502-U2990PeptideMeter2025-Q199.003.31—Buyer-sourced1MARGINAL
AX-2025-020835IpamorelinCPCCPC-2503-J1794Medutest2025-Q198.076.43—Buyer-sourced0FAIL
AX-2025-020826ThymalinCPCCPC-2501-V2021Janoshik2025-Q1N/A6.67—Buyer-sourced1N/A
AX-2025-020689SelankSGNSGN-2409-H8807Medutest2025-Q198.085.9692.9Buyer-sourced1FAIL
AX-2025-020640TirzepatideGL BiochemGLBI-2412-R8446PeptideMeter2025-Q199.004.0599.1Buyer-sourced0PASS
AX-2025-020296BPC-157GGPepsGGPE-2502-S2559Nordanalyt2025-Q199.502.36—Supplier-supplied0PASS
AX-2025-019650GHRP-2TFCTFC-2502-D2333Janoshik2025-Q199.365.50104.7Buyer-sourced0PASS
AX-2025-019064MK-677 (Ibutamoren mesylate)GSPGSP-2501-R2783PeptideMeter2025-Q199.415.84—Buyer-sourced0FAIL
AX-2025-018851DihexaFGPFGP-2408-S8496PeptideMeter2025-Q199.336.5388.9Buyer-sourced1MARGINAL
AX-2025-018828BPC-157FGPFGP-2409-Y8596Nordanalyt2025-Q199.935.12—Buyer-sourced0PASS
AX-2025-018441SemaglutideWWBWWB-2501-Y2776Janoshik2025-Q199.094.05—Buyer-sourced0PASS
AX-2025-018440SemaglutideWWBWWB-2501-Y2776Kestrel2025-Q199.934.07102.8Buyer-sourced0PASS
AX-2025-020651GHRP-6SGNSGN-2411-N8496Medutest2025-Q199.543.75106.4Buyer-sourced2FAIL
AX-2025-020509MOTS-cSSASSA-2501-M6154Janoshik2025-Q198.102.53102.8Buyer-sourced0PASS
AX-2025-020002RetatrutideSWBSWB-2411-R7167PeptideMeter2025-Q197.654.16—Buyer-sourced0PASS
AX-2025-019955TB-500HJHJ-2501-A6454Janoshik2025-Q199.694.40—Buyer-sourced1MARGINAL
AX-2025-019066MK-677 (Ibutamoren mesylate)GSPGSP-2501-R2783Medutest2025-Q199.626.0291.2Buyer-sourced0FAIL
AX-2025-018767BPC-157QSCQSC-2412-D7527Janoshik2025-Q199.436.9198.5Buyer-sourced0PASS
AX-2025-018685TB-500QSCQSC-2411-X6249PeptideMeter2025-Q199.495.63—Buyer-sourced1FAIL
AX-2025-018438SemaglutideWWBWWB-2501-Y2776Medutest2025-Q199.684.21—Laboratory-retained0PASS
AX-2025-021175SS-31 (Elamipretide)PPGPPG-2411-D6795Janoshik2025-Q199.465.36105.7Buyer-sourced0PASS
AX-2025-020946BPC-157WXTWXT-2501-J3079Nordanalyt2025-Q199.005.30—Buyer-sourced0PASS
AX-2025-020767SemaglutideSGNSGN-2410-D9265PeptideMeter2025-Q198.175.3891.3Buyer-sourced0PASS
AX-2025-020646TirzepatideGL BiochemGLBI-2412-R8446Medutest2025-Q199.464.55—Buyer-sourced0PASS
AX-2025-019830KPVHomopeptideHOMO-2411-P5026PeptideMeter2025-Q198.934.8393.5Buyer-sourced1FAIL
AX-2025-019137TesamorelinGSPGSP-2501-G3708PeptideMeter2025-Q198.064.56—Buyer-sourced0PASS
AX-2025-018420SemaglutideWWBWWB-2501-S2183PeptideMeter2025-Q198.903.8894.1Buyer-sourced0PASS
AX-2025-020712IGF-1 LR3SGNSGN-2409-D9295Nordanalyt2025-Q197.955.99103.0Buyer-sourced0PASS
AX-2025-019900TirzepatideHJHJ-2501-P5963PeptideMeter2025-Q198.132.84—Buyer-sourced0PASS